Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The diverse functions of FAT1 in cancer progression: good, bad, or ugly?
Abstract FAT atypical cadherin 1 (FAT1) is among the most frequently mutated genes in
many types of cancer. Its highest mutation rate is found in head and neck squamous cell …
many types of cancer. Its highest mutation rate is found in head and neck squamous cell …
Favorable immune checkpoint inhibitor outcome of patients with melanoma and NSCLC harboring FAT1 mutations
W Zhang, Y Tang, Y Guo, Y Kong, F Shi… - NPJ Precision …, 2022 - nature.com
Immune checkpoint inhibitors (ICIs) are most commonly used for melanoma and non-small
cell lung cancer (NSCLC) patients. FAT atypical cadherin 1 (FAT1), which frequently mutates …
cell lung cancer (NSCLC) patients. FAT atypical cadherin 1 (FAT1), which frequently mutates …
[HTML][HTML] Integrating genetic alterations and the Hippo Pathway in head and neck squamous cell carcinoma for future precision medicine
Genetic alterations and dysregulation of signaling pathways are indispensable for the
initiation and progression of cancer. Understanding the genetic, molecular, and signaling …
initiation and progression of cancer. Understanding the genetic, molecular, and signaling …
Prognostic impact of caspase‐8 mutation in oral cavity squamous cell carcinoma
Objective Identifying the drive genes and inhibiting their significant signals were persistently
the main concepts in cancer treatment. However, for oral cavity squamous cell carcinoma …
the main concepts in cancer treatment. However, for oral cavity squamous cell carcinoma …
YAP-driven malignant reprogramming of oral epithelial stem cells at single cell resolution
Tumor initiation represents the first step in tumorigenesis during which normal progenitor
cells undergo cell fate transition to cancer. Capturing this process as it occurs in vivo …
cells undergo cell fate transition to cancer. Capturing this process as it occurs in vivo …
SMAC mimetic drives microglia phenotype and glioblastoma immune microenvironment
E Snacel-Fazy, A Soubéran, M Grange, K Joseph… - Cell Death & …, 2024 - nature.com
Tumor-associated macrophages/microglia (TAMs) are highly plastic and heterogeneous
immune cells that can be immune-supportive or tumor-supportive depending of the …
immune cells that can be immune-supportive or tumor-supportive depending of the …
Exploring the impact of GSTM1 as a novel molecular determinant of survival in head and neck cancer patients of African descent
F Yang, F Chen, C Shay, GZ Chen, NF Saba… - Journal of Experimental & …, 2024 - Springer
Abstract Background Blacks/African American (BAA) patients diagnosed with head and neck
squamous cell carcinoma (HNSCC) have worse survival outcomes than White patients …
squamous cell carcinoma (HNSCC) have worse survival outcomes than White patients …
[HTML][HTML] Genetic mutations associated with inflammatory response caused by HPV integration in oropharyngeal squamous cell carcinoma
M Atique, I Muniz, F Farshadi, M Hier, A Mlynarek… - Biomedicines, 2023 - mdpi.com
(1) Background: Head and neck cancer (HNC) ranks as the sixth most prevalent cancer in
the world. In addition to the traditional risk factors such as alcohol and tobacco consumption …
the world. In addition to the traditional risk factors such as alcohol and tobacco consumption …
Identification of hub genes distinguishing subtypes in endometrial stromal sarcoma through comprehensive bioinformatics analysis
R Zhang, W Zhao, X Zhu, Y Liu, Q Ding, C Yang… - Scientific Reports, 2024 - nature.com
Diagnosing low-grade and high-grade endometrial stromal sarcoma (LG-ESS and HG-ESS)
is a challenge. This study aimed to identify biomarkers. 22 ESS cases were analyzed using …
is a challenge. This study aimed to identify biomarkers. 22 ESS cases were analyzed using …
[HTML][HTML] Phase II trial of CDX-3379 and cetuximab in recurrent/metastatic, HPV-negative, cetuximab-resistant head and neck cancer
Simple Summary This phase II, Simon 2-stage, multicenter study evaluated the efficacy of
the combination of CDX-3379 and cetuximab, monoclonal antibodies against ErbB3 and …
the combination of CDX-3379 and cetuximab, monoclonal antibodies against ErbB3 and …